Table 1.
Patient | Age | VAS Scores | Onset of effect (day) | Onset of lose of effect (month) | Duration of complaint (year) | |||||
---|---|---|---|---|---|---|---|---|---|---|
Pre-op | 2.w | 1.m | 3.m | 4.m | 6.m | |||||
1 | 25 | 8 | 1 | 1 | 0 | 2 | 6 | 10 | 4 | 1 |
2 | 23 | 5 | 1 | 1 | 3 | 4 | 5 | 13 | 3 | 4 |
3 | 24 | 7 | 5 | 1 | 1 | 1 | 7 | 14 | 6 | 1 |
4 | 29 | 8 | 3 | 1 | 0 | 0 | 3 | 14 | 5 | 8 |
5 | 55 | 8 | 7 | 6 | 6 | 7 | 8 | 15 | 4 | 12 |
6 | 36 | 6 | 2 | 1 | 1 | 1 | 2 | 12 | 5,5 | 5 |
7 | 31 | 7 | 0 | 0 | 0 | 1 | 3 | 10 | 5 | 15 |
8 | 26 | 8 | 2 | 4 | 7 | 7 | 7 | 15 | 2,5 | 9 |
9 | 40 | 9 | 5 | 2 | 2 | 2 | 4 | 13 | 5 | 11 |
10 | 41 | 6 | 3 | 1 | 1 | 1 | 4 | 12 | 5 | 7 |
11 | 36 | 7 | 3 | 0 | 0 | 2 | 4 | 11 | 6 | 9 |
12 | 34 | 4 | 0 | 0 | 0 | 0 | 1 | 10 | 5 | 4 |
13 | 37 | 6 | 2 | 1 | 1 | 1 | 2 | 14 | 5 | 5 |
14 | 29 | 7 | 2 | 1 | 1 | 2 | 3 | 12 | 4,5 | 8 |
15 | 48 | 7 | 1 | 0 | 0 | 0 | 1 | 13 | 5,5 | 10 |
16 | 43 | 6 | 3 | 2 | 2 | 2 | 3 | 15 | 5 | 3 |
17 | 51 | 8 | 1 | 0 | 0 | 2 | 3 | 9 | 4 | 12 |
18 | 46 | 8 | 3 | 1 | 1 | 1 | 2 | 9 | 4 | 14 |
19 | 33 | 9 | 4 | 1 | 1 | 1 | 3 | 11 | 5 | 18 |
20 | 32 | 7 | 0 | 0 | 0 | 1 | 2 | 8 | 4 | 13 |
21 | 37 | 7 | 2 | 0 | 0 | 1 | 2 | 14 | 4 | 7 |
22 | 29 | 9 | 2 | 1 | 1 | 1 | 1 | 13 | 6 | 6 |
23 | 42 | 8 | 7 | 7 | 7 | 7 | 7 | 13 | 5 | 15 |
24 | 35 | 6 | 0 | 0 | 0 | 0 | 1 | 12 | 5,5 | 13 |
25 | 34 | 7 | 1 | 0 | 0 | 0 | 1 | 14 | 5 | 11 |
Abbreviations. VAS: Visual Analogue Scale, BTXA: Botulinum Toxin A, w: week, m: month.